These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20082192)

  • 21. Ionic mechanisms of ischemia-related ventricular arrhythmias.
    Ducceschi V; Di Micco G; Sarubbi B; Russo B; Santangelo L; Iacono A
    Clin Cardiol; 1996 Apr; 19(4):325-31. PubMed ID: 8706374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review.
    Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ
    Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [How to: clinical use of antiarrhythmic drugs].
    Hillmann HAK; Betz K; Linz D; Duncker D
    Herzschrittmacherther Elektrophysiol; 2023 Mar; 34(1):82-90. PubMed ID: 36692540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs.
    Sutanto H; Laudy L; Clerx M; Dobrev D; Crijns HJGM; Heijman J
    Pharmacol Res; 2019 Oct; 148():104444. PubMed ID: 31493513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ionic mechanisms of action of class III antiarrhythmic drugs].
    Kuz'min VS; Rozenshtraukh LV
    Kardiologiia; 2010; 50(7):49-61. PubMed ID: 20659045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular and ionic specificity of antiarrhythmic drug actions.
    Nattel S
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):272-82. PubMed ID: 10090234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigational antiarrhythmic agents: promising drugs in early clinical development.
    Heijman J; Ghezelbash S; Dobrev D
    Expert Opin Investig Drugs; 2017 Aug; 26(8):897-907. PubMed ID: 28691539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation.
    Dobrev D
    J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of alcohol on cardiac electrophysiology and arrhythmogenesis: Insights from multiscale in silico analyses.
    Sutanto H; Cluitmans MJM; Dobrev D; Volders PGA; Bébarová M; Heijman J
    J Mol Cell Cardiol; 2020 Sep; 146():69-83. PubMed ID: 32710981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging antiarrhythmic agents: a personal view from the Far East.
    Hashimoto K
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):23-9. PubMed ID: 21352067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
    Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
    Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of amiodarone in contemporary management of complex cardiac arrhythmias.
    Mujović N; Dobrev D; Marinković M; Russo V; Potpara TS
    Pharmacol Res; 2020 Jan; 151():104521. PubMed ID: 31756386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol.
    Osadchii OE
    Exp Physiol; 2019 Apr; 104(4):490-504. PubMed ID: 30758086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic treatment: an overview.
    Bigger JT
    Am J Cardiol; 1984 Feb; 53(5):8B-16B. PubMed ID: 6364771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.